McKesson Corporation (MCK)

Over the last three years, diversification has fallen out of fashion. When investors can make 20% or higher returns in technology stocks and even more from the Magnificent 7, the idea of investing in ...

McKesson (MCK) closed the most recent trading day at $679.33, moving +1.13% from the previous trading session.

IRVING, Texas--(BUSINESS WIRE)--Register to attend McKesson ideaShare, a premier community pharmacy annual education and networking event, in Nashville from July 10-13, 2025.

McKesson acquires 80% ownership in PRISM Vision Holdings, diversifying its business into the high-growth area of ophthalmology. The deal is to be accretive this year.

MCK IS UP OVER 14 POINTS AFTER THE TRADEPULSE ALERT

An aging U.S. population is increasing the demand for medication, and this company delivers.

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) today announced the completion of its previously announced acquisition of a controlling interest in PRISM Vision Holdings, LLC, a leadi...

In the most recent trading session, McKesson (MCK) closed at $672.99, indicating a +0.74% shift from the previous trading day.

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employe...

I maintain a 'Strong Buy' rating on McKesson with a fair value of $723 per share due to its robust oncology network and strong growth prospects. McKesson's minimal exposure to US-Mexico-Canada tariffs...